Metropolis Healthcare Limited
ListedMainboardHealthcare · NSE / BSE
Incorporated in 1980, Mumbai-based Metropolis Healthcare Limited is a chain of diagnostic companies operating 106 clinical laboratories and 1,130 collection centers across seven countries, with a presence in 18 states and 173 cities in India for disease monitoring, early detection, and diagnostic screening. The company offers 3,480 clinical laboratory tests and 524 profiles, combining various tests for specific diseases, and serves around 7.7 million patients annually, conducting approximately 16 million tests. It also provides analytical and support services for clinical research projects and follows a 'hub and spoke' model to enhance service delivery. Internationally, Metropolis has laboratory operations in Ghana, Zambia, Kenya, Sri Lanka, and Mauritius, and offers third-party services in UAE, Nepal, Nigeria, and Oman. The company has been recognized for excellence in customer service and delivery by Biotrains, for service excellence by FICCI, and as "best in health and fitness" by LH Insights in 2018.
Price Band
₹877 – ₹880
Issue Size
₹1204 Cr
Lot Size
17 shares
GMP
—
Est. Listing
₹880
at current GMP
Subscribed
—
Open
3 Apr 2019
Close
5 Apr 2019
Allotment
10 Apr 2019
Refund
11 Apr 2019
Demat Credit
12 Apr 2019
Listing
15 Apr 2019
Last updated 12 days ago
Live Grey Market Premium
Metropolis Healthcare Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹00.0%
Issue Price (Upper)
₹880
Band: ₹877 – ₹880
Estimated Listing Price
₹880
Upper price + GMP
Lot Size
17 shares
Min investment ₹14,960
Estimated Profit / Lot
₹0
17 × ₹0
Metropolis Healthcare Limited GMP Historical Trend
GMP History
Grey Market Premium trend
—
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹880 |
| 30 Oct 2026 | — | 0.0% | ₹880 |
| 29 Oct 2026 | — | 0.0% | ₹880 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Metropolis Healthcare Limited Public Issue & Market Profile
Metropolis Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹1,204 Crores. The shares are offered at a price band of ₹877 to ₹880 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2019-04-05, the basis of allotment is scheduled to be finalized on 2019-04-10. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Ltd) or the BSE allotment checking window.
Frequently Asked Questions
What is Metropolis Healthcare Limited IPO GMP today?
The latest grey market premium for Metropolis Healthcare Limited IPO is ₹0, which indicates an expected listing price of ₹880.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.